Skip to main content

Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis

10Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

The introduction of modified-release (MR) prednisone adds a drug with encouraging potential to the armamentarium of the rheumatologist. In particular, for patients experiencing a reduced quality of life due to prolonged morning stiffness, it is a promising therapeutic approach. Two clinical trials and one open-label observational study investigated the effectiveness of MR prednisone in reducing rheumatoid arthritis-related morning stiffness for both new and current users of corticosteroids. The efficacy and safety of MR prednisone use in rheumatoid arthritis patients are reviewed in this article. This includes pivotal trials as well as pathophysiological considerations and clinical implications.

Cite

CITATION STYLE

APA

Krasselt, M., & Baerwald, C. (2016). Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis. Drug Design, Development and Therapy, 10, 1047–1058. https://doi.org/10.2147/DDDT.S87792

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free